Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Trellus Health plc delivers digital health management services for long-term illnesses, primarily serving businesses and insurance companies. The cornerstone of their offerings is TrellusElevate, a secure, proprietary technology platform compliant with HIPAA regulations. This system enables the remote coordination and provision of individualized healthcare via telemedicine. Patients utilizing the platform gain access to dedicated care teams, comprehensive educational materials, and remote monitoring tools. This service specifically addresses inflammatory bowel diseases (IBD), encompassing chronic and incurable conditions like Crohn's Disease and ulcerative colitis. Founded in 2020, Trellus Health plc is headquartered in White Plains, New York.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is undervalued on EV/EBITDA.